FATE peer analysis
Fate Therapeutics (FATE) against its competitors: price, today's move, 1-year return and market value side by side.
- FATE's peers: ABOS (Acumen Pharmaceuticals), ALEC (Alector), CRBP (Corbus), INO (Inovio Pharmaceuticals), MOLN (Molecular Partners), NKTX (Nkarta), PEPG (PepGen), PRLD (Prelude Therapeutics Incorporated).
FATE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals | $0.18 | -9.11% | -88.66% | $12.71M |
| ALEC Alector | $2.33 | 1.52% | 91.39% | $347.63M |
| CRBP Corbus | $2.09 | -14.17% | -82.32% | $43.07M |
| INO Inovio Pharmaceuticals | $1.84 | 7.60% | 3.37% | $127.13M |
| MOLN Molecular Partners | $2.67 | -6.82% | – | $102.16M |
| NKTX Nkarta | $1.15 | 2.68% | -35.75% | $82.37M |
| PEPG PepGen | $3.79 | -3.56% | -31.46% | $262.50M |
| PRLD Prelude Therapeutics Incorporated | $3.22 | -1.08% | 92.81% | $257.83M |
| VOR Vor Biopharma | $19.20 | 3.67% | 145.52% | $1.18B |
| FATE Fate Therapeutics | $0.96 | -5.06% | -8.68% | $116.57M |